Pharmacogenomic considerations in drug delivery

Area of Science:

• Pharmacology and Drug Delivery
• Genetics and Personalized Medicine

Background:

• Drug delivery aims for optimal therapeutic concentrations at the target site.
• Drug concentration is governed by absorption, distribution, metabolism, and elimination (ADME) processes.
• Interindividual variability in drug response is influenced by genetic factors.

Purpose of the Study:

• To highlight the significance of genetic polymorphisms in drug delivery.
• To explore the impact of pharmacogenomics on drug concentration and efficacy.

Main Methods:

• Review of pharmacokinetic and pharmacodynamic principles.
• Identification of genetic polymorphisms in drug-metabolizing enzymes, transporters, and targets.

Main Results:

• Genetic variations significantly contribute to interindividual differences in drug behavior.
• Polymorphisms in key genes can alter drug metabolism, transport, and target interaction.
• These genetic factors directly influence the concentration of free drug and the resulting therapeutic effect.

Conclusions:

• Pharmacogenomic considerations are crucial for designing effective drug delivery systems.
• Tailoring drug delivery based on an individual's genetic profile can optimize therapeutic outcomes.
• Understanding genetic influences allows for more precise and personalized medicine approaches.